Evidence map›Paper›PMID 26187465›Full record

ArticleThe Journal of biological chemistry2015

Inhibition of Glutathione Production Induces Macrophage CD36 Expression and Enhances Cellular-oxidized Low Density Lipoprotein (oxLDL) Uptake.

Xiaoxiao Yang, Hui Yao, Yuanli Chen, Lei Sun, Yan Li, Xingzhe Ma, Shengzhong Duan, Xiaoju Li, Rong Xiang, Jihong Han and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Sonodynamic therapy for the treatment of atherosclerosis.Journal of pharmaceutical analysis · 2024
    Review
  3. Article
  4. The function of CD36 inFrontiers in immunology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Macrophage fatty acid oxidation inhibits atherosclerosis progression.Journal of molecular and cellular cardiology · 2019
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xiaoxiao YangFrom the State Key Laboratory of Medicinal Chemical Biology, Colleges of Life Sciences and.
Hui YaoFrom the State Key Laboratory of Medicinal Chemical Biology, Colleges of Life Sciences and.
Yuanli ChenFrom the State Key Laboratory of Medicinal Chemical Biology, Medicine, Collaborative Innovation Center of Biotherapy, Nankai University, Tianjin 300071, China and.
Lei SunColleges of Life Sciences and.
Yan LiColleges of Life Sciences and.
Xingzhe MaColleges of Life Sciences and.
Shengzhong DuanInstitute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Xiaoju LiColleges of Life Sciences and.
Rong XiangFrom the State Key Laboratory of Medicinal Chemical Biology, Medicine.
Jihong HanFrom the State Key Laboratory of Medicinal Chemical Biology, Colleges of Life Sciences and Collaborative Innovation Center of Biotherapy, Nankai University, Tianjin 300071, China and jihonghan2008@nankai.edu.cn.
Yajun DuanFrom the State Key Laboratory of Medicinal Chemical Biology, Colleges of Life Sciences and yajunduan@nankai.edu.cn.
Nankai University · CNShanghai Institutes for Biological Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The glutathione (GSH)-dependent antioxidant system has been demonstrated to inhibit atherosclerosis. Macrophage CD36 uptakes oxidized low density lipoprotein (oxLDL) thereby facilitating foam cell formation and development of atherosclerosis. It remains unknown if GSH can influence macrophage CD36 expression and cellular oxLDL uptake directly. Herein we report that treatment of macrophages with l-buthionine-S,R-sulfoximine (BSO) decreased cellular GSH production and ratios of GSH to glutathione disulfide (GSH/GSSG) while increasing production of reactive oxygen species. Associated with decreased GSH levels, macrophage CD36 expression was increased, which resulted in enhanced cellular oxLDL uptake. In contrast, N-acetyl cysteine and antioxidant enzyme (catalase or superoxide dismutase) blocked BSO-induced CD36 expression as well as oxLDL uptake. In vivo, administration of mice with BSO increased CD36 expression in peritoneal macrophages and kidneys. BSO had no effect on CD36 mRNA expression and promoter activity but still induced CD36 protein expression in macrophages lacking peroxisome proliferator-activated receptor γ expression, suggesting it induced CD36 expression at the translational level. Indeed, we determined that BSO enhanced CD36 translational efficiency. Taken together, our study demonstrates that cellular GSH levels and GSH/GSSG status can regulate macrophage CD36 expression and cellular oxLDL uptake and demonstrate an important anti-atherogenic function of the GSH-dependent antioxidant system by providing a novel molecular mechanism.

Indexed as

AcetylcysteineAnimalsAntimetabolitesBlotting, WesternButhionine SulfoximineCD36 AntigensCell LineFree Radical ScavengersGene ExpressionGlutathioneGlutathione DisulfideLipoproteins, LDLMacrophagesMice, Inbred C57BLMice, KnockoutPPAR gammaAcetylcysteineAntimetabolitesButhionine SulfoximineCD36 AntigensFree Radical ScavengersGlutathioneGlutathione DisulfideLipoproteins, LDLoxidized low density lipoproteinPPAR gammaReactive Oxygen SpeciesantioxidantatherosclerosisCD36foam cellglutamate-cysteine ligaseglutathionemacrophageperoxisome proliferator-activated receptor (PPAR)translation regulation

Identifiers

PMID26187465
PMCPMC4571935
OpenAlexW1947438645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.